LIS
CORT icon

Legacy Investment Solutions’s Corcept Therapeutics CORT Stock Holding History

Legacy Investment Solutions’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$1.25K Buy
+17
New +$1.23K ﹤0.01% 570
2024
Q4 		$1.91K Buy
28
+11
+65% +$576 ﹤0.01% 505
2024
Q3 		$960 Buy
+17
New +$604 ﹤0.01% 550

Other funds holding CORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Legacy Investment Solutions's CORT Position: Q2 2025 in Review

Legacy Investment Solutions opened a new position in Corcept Therapeutics (CORT) in Q2 2025: 17 shares worth $1.25K. The stake represents ﹤0.01% of the portfolio and ranks #570 among its holdings. This is a return to the name: Legacy Investment Solutions previously reported a position in CORT as recently as Q4 2024.

Legacy Investment Solutions first reported a position in CORT in Q3 2024 and has held it in 3 quarters since. The position peaked at $1.91K in Q4 2024. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2025.

  • Legacy Investment Solutions held 17 shares of Corcept Therapeutics worth $1.25K as of Q2 2025.
  • Corcept Therapeutics was a new Legacy Investment Solutions position in Q2 2025.
  • Corcept Therapeutics made up ﹤0.01% of Legacy Investment Solutions's portfolio in Q2 2025, its #570 holding.
  • Legacy Investment Solutions first reported a position in Corcept Therapeutics in Q3 2024 and has held it in 3 quarters since.
  • Legacy Investment Solutions's Corcept Therapeutics position peaked at $1.91K in Q4 2024.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2025.

Based on Legacy Investment Solutions's 13F filing for Q2 2025, filed 6 Aug 2025.